Synthetic Biologics to Host Microbiome Clinical Program Seminar in New York City
— Event to Highlight Company’s Two Phase 2 Clinical Programs: Treatment of Irritable Bowel Syndrome with Constipation and Prevention of C. difficile Infection — — Scheduled for Thursday, December 10, 2015 — ROCKVILLE, Md., Nov. 19, 2015 /PRNewswire/ — Synthetic Biologics, Inc. (NYSE MKT: SYN), a clinical-stage company focused on developing therapeutics to protect the gut […]
Synthetic Biologics to Host Microbiome Clinical Program Seminar in New York City Read More »